Safety study of Sonazoid for liver ultrasound in children
Part of Cancer, Digestive system clinical trials.
This trial tests a contrast agent called Sonazoid, which is used during an ultrasound to get clearer pictures of the liver. It is for children and teens who have one or more spots in the liver that need to be checked. The goal is to see if Sonazoid is safe and works well for children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 18 years old.
- You have at least one untreated spot in the liver (up to 8 spots, not counting cysts), less than 8 cm in size, seen on a recent ultrasound, CT, or MRI scan.
- A CT or MRI scan with contrast was done in the past month, or is planned within the next month.
- Your body weight is at least 3 kilograms (about 6.6 pounds).
- You have no known allergy to eggs or egg products, or you have a negative egg allergy test.
- If you are a girl who has started menstruating, you must have a negative pregnancy test and use birth control. Boys who are sexually active with a partner who could get pregnant must also use birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a special ultrasound contrast agent can help find liver cancer earlier in people with cirrhosis. It compares this method with other imaging tests to improve early detection and treatment planning.
This study tests if a special ultrasound dye is safe and useful in children to look at tumors, injury, or fluid in the belly when other tests haven't given clear answers.
This trial tests whether contrast-enhanced ultrasound can help find sentinel lymph nodes (the first nodes cancer may spread to) in people with melanoma, breast, or head and neck cancer. It may reduce the need for a radioactive tracer injection.
This study tests if non-invasive imaging (like ultrasound) can replace liver biopsies in children with liver disease. It may help avoid the need for a needle biopsy in the future.
This trial uses a special ultrasound with contrast dye to get a clearer picture of liver spots that other scans (CT, MRI, or PET) couldn't fully identify. The goal is to see if this ultrasound can help doctors make a more accurate diagnosis.
This study tests a new, more detailed ultrasound technique to better see liver tumors. It may help doctors understand your tumor better without extra procedures.
Hear when a new Focal Liver Lesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.